ATGAM 250MG INJECTION

Atgam 250mg Injection is formulated with Antithymocyte Immunoglobulins, a critical ingredient purified and sterilized. This gamma globulin is extracted from the plasma of horses immunized with human white blood cell components, making it a reliable and practical part of preventing organ rejection. Following a solid organ transplant, the body’s natural response is to identify the transplanted organ’s antigens as foreign, which can trigger an aggressive immune response and lead to rejection. To counteract this, immunosuppressive agents are administered to prevent organ rejection and ensure a successful transplant outcome. Atgam 250mg Injections are used to treat severe aplastic anemia, a condition where the bone marrow doesn’t produce enough blood cells. These injections help suppress the immune system and reduce the destruction of bone marrow cells, which in turn helps restore average blood cell production. Using Atgam 250mg Injections can minimize the need for high doses and prolonged use of corticosteroids in immunosuppressive treatments, which can reduce side effects and risks. However, individuals who have known hypersensitivity or previous severe allergic reactions to Atgam 250mg Injection or its components should avoid it. Additionally, live vaccines should be avoided during treatment, and individuals with active infections, especially severe or systemic diseases, should only receive treatment until the condition is appropriately treated and resolved.